Trump Picks Heidi Overton for FDA Commissioner: Here's What to Know

President Donald Trump has selected Heidi Overton, a White House aide, to become the next FDA Commissioner. Overton is currently the deputy director of the White House Domestic Policy Council and has played a key role in several of Trump's health initiatives during his second term. If confirmed by the Senate, Overton will face a number of challenges, balancing Trump's pro-regulatory stance, the interests of traditional Republicans, and the anti-corporate approach of Health Secretary Robert F. Kennedy Jr.

Overton's background includes a medical degree from the University of New Mexico and a doctoral degree in clinical investigation from Johns Hopkins University. Before joining Trump's administration, she served as the chief policy officer at the America First Policy Institute, a conservative think tank. During her tenure, Overton has actively promoted Trump's health priorities, including advocating for lower drug prices, faster cures, and more wins for Kennedy's Make America Healthy Again movement.

While Overton has been praised by Kennedy for her exceptional judgment and commitment to the American people, she will face scrutiny from the Senate Health, Education, Labor and Pensions Committee. Her confirmation hinges on approval from a predominantly Republican-led Senate. If confirmed, Overton will have to address the FDA's ongoing review of antidepressants, as well as the administration's efforts to roll back regulations surrounding abortion pills, which have drawn criticism from anti-abortion activists.